Condition: Thoracic Esophageal Squamous Cell Carcinoma · Sponsor: Sun Yat-Sen University Cancer Center
Patients with thoracic esophageal squamous cell carcinoma after total two-field lymph node dissection were randomized into the adjuvant chemotherapy group or the postoperative observation group
This description comes directly from the study's public registry record.
Peng Lin, professor · +86-20-87343314 · linpeng@sysucc.org.cn
Xing Ru Ping · +86-20-87343736 · xingrp@sysucc.org.cn
Always discuss trial participation with your own doctor first.
| Sun Yat-sen Uniersity Cancer Center | Guangzhou, Guangdong, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04174079